Axepharma: sector benchmark
Where does a company stand against its sector? Every ratio over five fiscal years, with its place among its peers and what that means, ready to print for your client.
Axepharma
Summary
Axepharma does better than half of its sector on 8 of the 9 ratios compared.
- Working-capital ratiobetter than 87%
- Long-term debt ratiobetter than 83%
- Return on assetsbetter than 81%
- Interest coveragebetter than 47%
Solvency and debt
Solvency is above 80% of 32,488 sector peers: in the most favourable quarter.
Position against the sector stable since 2021.
Debt to equity is below 64% of 32,106 sector peers: more favourable than the median.
Position against the sector stable since 2021.
The long-term debt ratio is below 83% of 21,157 sector peers: in the most favourable quarter.
Position against the sector improving since 2021.
Interest coverage is below 53% of 29,199 sector peers: less favourable than the median.
Position against the sector stable since 2021.
Liquidity
The current ratio is above 80% of 32,316 sector peers: in the most favourable quarter.
Position against the sector stable since 2021.
The quick ratio is above 79% of 32,337 sector peers: in the most favourable quarter.
Position against the sector stable since 2021.
The working-capital ratio is above 87% of 32,412 sector peers: in the most favourable quarter.
Position against the sector stable since 2021.
Profitability
Return on equity is above 65% of 27,017 sector peers: more favourable than the median.
Position against the sector weakening since 2021.
Return on assets is above 81% of 32,568 sector peers: in the most favourable quarter.
Position against the sector weakening since 2021.
Not computable
Net margin, EBITDA margin, Gross margin, Days sales outstanding, Days payable outstanding, Days inventory. This company files the abbreviated or micro schema, in which turnover and purchases are optional; margins and credit terms therefore cannot be taken from its figures.
Source: filed annual accounts (NBB) and main activity (CBE register). Compared per fiscal year with each peer's latest statutory accounts; at least 30 peers per ratio. Prepared on 29 September 2026 via checked.be.